# EDGAR Filing Document

**Accession Number:** 0001698530
**File Stem:** 0002046701-26-000005
**Filing Date:** 2026-1
**Character Count:** 7803
**Document Hash:** 364342f1771ba28743f088d0caafe053
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002046701-26-000005.hdr.sgml**: 20260120

**ACCESSION NUMBER**: 0002046701-26-000005

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260120

**DATE AS OF CHANGE**: 20260120

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EXICURE, INC.
- **CENTRAL INDEX KEY:** 0001698530
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 815333008
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90023
- **FILM NUMBER:** 26544131

**BUSINESS ADDRESS:**
- **STREET 1:** 2430 N. HALSTED ST.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60614
- **BUSINESS PHONE:** 847-673-1707

**MAIL ADDRESS:**
- **STREET 1:** 2430 N. HALSTED ST.
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60614

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Max-1 Acquisition Corp
- **DATE OF NAME CHANGE:** 20170221
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Exicure HiTron Inc.
- **CENTRAL INDEX KEY:** 0002046701

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** M5
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 99-13 MASAN-GIL, MIYANG-MYEON
- **CITY:** ANSEONG-SI, GYEONGGI-DO
- **STATE:** MA
- **ZIP:** 17601
- **BUSINESS PHONE:** 821062202280

**MAIL ADDRESS:**
- **STREET 1:** 99-13 MASAN-GIL, MIYANG-MYEON
- **CITY:** ANSEONG-SI, GYEONGGI-DO
- **STATE:** MA
- **ZIP:** 17601

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HiTron Systems Inc.
- **DATE OF NAME CHANGE:** 20241127

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 4)**

**EXICURE, INC.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**30205M309**

*(CUSIP Number)*

**Dario Lee**<br>1500 W Georgia st<br>Suite 1323<br>Vancouver A1 V7Y1C6<br>2368386944

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**01/16/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **30205M309** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Exicure HiTron Inc.** | Name of reporting person<br>**Exicure HiTron Inc.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**M5** | Citizenship or place of organization<br>**M5** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1857314.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1857314.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1857314.00** | Aggregate amount beneficially owned by each reporting person<br>**1857314.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**29.2%** | Percent of class represented by amount in Row (11)<br>**29.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
EXICURE, INC.

**(c) Address of Issuer's Principal Executive Offices:**
2430 N. HALSTED ST., CHICAGO, IL, 60614

This Amendment No. 4 (this Amendment) to the statement on Schedule 13D with respect to the beneficial ownership of shares of common stock, par value $0.0001 per share (the Shares), of Exicure, Inc., a Delaware corporation (the Issuer), filed by Exicure HiTron Inc., a South Korean corporation (the Reporting Person), amends and supplements the statement on Schedule 13D originally filed on November 29, 2024, as amended by Amendment No. 1 filed on November 19, 2024, Amendment No. 2 filed on September 9, 2025, and Amendment No. 3 filed on January 9, 2026 (collectively, the Original Statement), as set forth below.

All capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Statement. Except as specifically amended by this Amendment, the Original Statement remains unchanged

**Item 4. Purpose of Transaction**

Item 4 of the Original Statement is hereby amended and supplemented as follows:
The Reporting Person entered into share transfer agreements dated December 30, 2025 (the Share Transfer Agreements) and agreed to transfer (the Share Transfer) an aggregate of 734,747 Shares at a price of $4.50 per Share for aggregate proceeds of $3,306,361.5, as follows:

Name of Transferee	Number of Shares	Proceeds
Daolam Co,. Ltd	246,913	             $1,111,108.5
Lee So Jung	        243,918	             $1,097,631
Kim Jun Sue	        243,916	             $1,097,622

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5(a) of the Original Statement is hereby amended and restated as follows:

The percentage of beneficial ownership reported in this Item 5, and on the Reporting Persons cover page to this Amendment, is based on a total of 6,373,869 shares of common stock, which represents the number of shares of common stock reported as outstanding on November 3, 2025, as reported in the Issuers Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025. All share numbers reported herein, and on the Reporting Persons cover page to this Amendment, are as of January 16, 2026, and give effect to the share transfers described herein. The cover page to this Amendment is incorporated by reference in its entirety into this Item 5. As of January 16, 2026. The Reporting Person is the beneficial owner of 1,857,314 shares of Common Stock, representing approximately 29.2% of the outstanding shares of Common Stock.

**(b)**
—

**(c)**
—

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of the Original Statement is hereby supplemented as follows:
The Reporting Person entered into share transfer agreements  and agreed to transfer an aggregate of 734,747 Shares at a price of $4.50 per Share for aggregate proceeds of $3,306,361.5, as follows:

Name of Transferee	Number of Shares	Proceeds
Daolam Co,. Ltd	246,913	             $1,111,108.5
Lee So Jung	        243,918	             $1,097,631
Kim Jun Sue	        243,916	             $1,097,622

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Exicure HiTron Inc.

**Signature:** Young Chul Han

**Name/Title:** CEO

**Date:** 01/20/2026